June 2013 | OncologyLive

Holland's Research Focuses on Needs of Older Patients

July 25, 2013

When Jimmie C. Holland, MD, conducts research, geriatric cancer patients are often her focus. Holland has studied telephone intervention as a way to monitor stress in patients aged 65 and older. She discussed the effort with OncologyLive.

UNC Research Leader Sees Multiple Roles, Many Questions in NF-κB Activity

July 17, 2013

Albert S. Baldwin, Jr, PhD, focuses on understanding the regulation and biological functions of NF-κB and its role in disease, particularly in cancer, in a laboratory he heads at the UNC Lineberger Comprehensive Cancer Center.

Big Moment for Nanotech: Oncology Therapeutics Poised for a Leap

July 02, 2013

The translation of scientific advances in nanotechnology into cancer therapies, in vitro assays, and imaging tools is poised for takeoff, amid fresh excitement among investors and a mushrooming of findings from leading research institutions.

The Inflammation Link: NF-κB Remains a Difficult but Intriguing Target

June 28, 2013

The complex regulation of NF-κB activation has presented significant challenges for the development of anticancer agents, but researchers are now beginning to better understand and embrace this complexity to drive development of a variety of novel NF-κB-targeting strategies.

Abiraterone Slows mCRPC Before Chemotherapy

June 21, 2013

Progression-free survival doubled in men with metastatic castration-resistant prostate cancer with no chemotherapy exposure who were treated with abiraterone acetate plus prednisone versus prednisone alone.